Healthcare provider profile · identity verified

Rennie C.S. Roque, MD

Internal Medicine · ANTIOCH, CA · NPI 1356493167

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	875	304
Amlodipine Besylate	Amlodipine Besylate	608	213
Losartan Potassium	Losartan Potassium	402	144
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	387	72
Atenolol	Atenolol	382	129
Levothyroxine Sodium	Levothyroxine Sodium	264	86
Lisinopril	Lisinopril	257	95
Pantoprazole Sodium	Pantoprazole Sodium	236	78
Fluticasone Propionate	Fluticasone Propionate	224	87
Albuterol Sulfate Hfa	Albuterol Sulfate	211	107
Famotidine	Famotidine	190	81
Tamsulosin Hcl	Tamsulosin Hcl	186	72
Metformin Hcl Er	Metformin Hcl	182	65
Jardiance	Empagliflozin	177	61
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	177	68
Lovastatin	Lovastatin	177	61
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	172	63
Metformin Hcl	Metformin Hcl	170	60
Ibuprofen	Ibuprofen	166	81
Hydrochlorothiazide	Hydrochlorothiazide	155	66
Glipizide	Glipizide	154	58
Furosemide	Furosemide	151	63
Metoprolol Tartrate	Metoprolol Tartrate	139	51
Alvesco	Ciclesonide	138	66
Allopurinol	Allopurinol	131	51
Wixela Inhub	Fluticasone Propion/Salmeterol	128	47
Montelukast Sodium	Montelukast Sodium	127	51
Prednisone	Prednisone	126	90
Trazodone Hcl	Trazodone Hcl	113	49
Gabapentin	Gabapentin	104	41
Tizanidine Hcl	Tizanidine Hcl	103	48
Shingrix	Varicella-Zoster Ge/As01b/Pf	99	64
Cephalexin	Cephalexin	96	68
Metoprolol Succinate	Metoprolol Succinate	96	35
Fluocinonide	Fluocinonide	95	43
Hydralazine Hcl	Hydralazine Hcl	94	34
Simvastatin	Simvastatin	91	35
Alendronate Sodium	Alendronate Sodium	90	31
Pradaxa	Dabigatran Etexilate Mesylate	89	25
Colchicine	Colchicine	84	32
Finasteride	Finasteride	76	26
Pravastatin Sodium	Pravastatin Sodium	74	28
Ozempic	Semaglutide	71	13
Glipizide Er	Glipizide	70	22
Sertraline Hcl	Sertraline Hcl	66	28
Carvedilol	Carvedilol	65	21
Duloxetine Hcl	Duloxetine Hcl	65	26
Rosuvastatin Calcium	Rosuvastatin Calcium	63	25
Clobetasol Propionate	Clobetasol Propionate	60	32
Terazosin Hcl	Terazosin Hcl	58	24
Amoxicillin	Amoxicillin	56	41
Potassium Chloride	Potassium Chloride	55	18
Azithromycin	Azithromycin	54	48
Omeprazole	Omeprazole	51	18
Lorazepam	Lorazepam	49	13
Mirtazapine	Mirtazapine	48	22
Spiriva Respimat	Tiotropium Bromide	48	20
Triamcinolone Acetonide	Triamcinolone Acetonide	47	29
Breyna	Budesonide/Formoterol Fumarate	46	18
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	45	suppressed
Citalopram Hbr	Citalopram Hydrobromide	42	19
Cefpodoxime Proxetil	Cefpodoxime Proxetil	40	29
Isosorbide Mononitrate Er	Isosorbide Mononitrate	38	13
Fluoxetine Hcl	Fluoxetine Hcl	37	14
Ropinirole Hcl	Ropinirole Hcl	37	11
Venlafaxine Hcl Er	Venlafaxine Hcl	37	12
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	37	12
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	35	35
Hydrocortisone	Hydrocortisone	35	11
Nabumetone	Nabumetone	34	14
Naproxen	Naproxen	33	15
Fluconazole	Fluconazole	32	17
Sumatriptan Succinate	Sumatriptan Succinate	30	16
Tramadol Hcl	Tramadol Hcl	30	suppressed
Warfarin Sodium	Warfarin Sodium	30	12
Humulin N	Insulin Nph Human Isophane	29	13
Humulin N Kwikpen	Insulin Nph Human Isophane	27	13
Meloxicam	Meloxicam	27	12
Spironolactone	Spironolactone	27	suppressed
Clopidogrel	Clopidogrel Bisulfate	26	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	25	suppressed
Oxycodone Hcl	Oxycodone Hcl	25	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	24	23
Arexvy	Rsvpref3 Antigen/As01e/Pf	22	22
Ondansetron Hcl	Ondansetron Hcl	22	11
Propranolol Hcl	Propranolol Hcl	21	suppressed
Topiramate	Topiramate	21	12
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	21	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	20	suppressed
Nystatin	Nystatin	20	14
Paxlovid	Nirmatrelvir/Ritonavir	20	20
Temazepam	Temazepam	20	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	19	13
Humulin R	Insulin Regular, Human	19	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	19	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	19	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	18	11
Nortriptyline Hcl	Nortriptyline Hcl	18	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Azelastine Hcl	Azelastine Hcl	17	suppressed
Lactulose	Lactulose	17	suppressed
Ondansetron Odt	Ondansetron	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	14
Nitroglycerin	Nitroglycerin	16	suppressed
Rizatriptan	Rizatriptan Benzoate	15	suppressed
Trospium Chloride	Trospium Chloride	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	15	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	14	suppressed
Glycopyrrolate	Glycopyrrolate	14	suppressed
Scopolamine	Scopolamine	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	13	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	11
Oxazepam	Oxazepam	12	suppressed
Baclofen	Baclofen	11	suppressed
Diazepam	Diazepam	11	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error